Evidence map›Paper›PMID 42663497›Full record

SynthesisEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2026

Non-linear associations between blood pressure and clinical outcomes in atrial fibrillation: a systematic review and dose-response meta-analysis.

Elnaz Shahmohamadi, Alessandra Pina, Adrian D Elliott, Jonathan P Ariyaratnam, Melissa E Middeldorp, Prashanthan Sanders

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elnaz ShahmohamadiCentre for Heart Rhythm Disorders, Adelaide University and Royal Adelaide Hospital, 1 Port Road, Adelaide SA, Adelaide 5000, Australia.ORCID 0000-0003-1912-9923
Alessandra PinaCentre for Heart Rhythm Disorders, Adelaide University and Royal Adelaide Hospital, 1 Port Road, Adelaide SA, Adelaide 5000, Australia.ORCID 0000-0001-5436-9899
Adrian D ElliottCentre for Heart Rhythm Disorders, Adelaide University and Royal Adelaide Hospital, 1 Port Road, Adelaide SA, Adelaide 5000, Australia.ORCID 0000-0002-5951-4239
Jonathan P AriyaratnamCentre for Heart Rhythm Disorders, Adelaide University and Royal Adelaide Hospital, 1 Port Road, Adelaide SA, Adelaide 5000, Australia.ORCID 0000-0002-8801-8402
Melissa E MiddeldorpCentre for Heart Rhythm Disorders, Adelaide University and Royal Adelaide Hospital, 1 Port Road, Adelaide SA, Adelaide 5000, Australia.ORCID 0000-0002-4106-9771
Prashanthan SandersCentre for Heart Rhythm Disorders, Adelaide University and Royal Adelaide Hospital, 1 Port Road, Adelaide SA, Adelaide 5000, Australia.ORCID 0000-0003-3803-8429

Funding

Adelaide UniversityNational Health and Medical Research Council of AustraliaNational Heart Foundation of Australia
6 · The paper itself

Abstract

aimsHypertension carries the highest attributable risk for atrial fibrillation (AF) and strongly influences clinical outcomes such as stroke and death; however, the optimal blood pressure targets in individuals with AF remain poorly defined. We aimed to characterize the dose-response relationship between systolic blood pressure (SBP) and diastolic blood pressure (DBP) and ischaemic stroke, all-cause mortality, and intracranial haemorrhage. METHODS AND

resultsWe systematically searched MEDLINE, Embase, and Scopus for studies reporting outcomes in AF stratified by SBP and DBP. A two-stage dose-response meta-analysis used restricted cubic splines to model non-linearity, with within-study correlation handled by the Greenland-Longnecker method. Twenty-three studies (17 cohorts; n = 476 750) were included. SBP demonstrated a U-shaped association with all-cause mortality, with the lowest risk at 134 mmHg (relative risks (RR) 0.92, 0.86-0.98 vs. 120 mmHg). DBP exhibited a J-shaped association, with the lowest risk at 83 mmHg (RR 0.99, 0.97-1.02). In contrast to mortality, the risks of ischaemic stroke, intracranial haemorrhage, and stroke or systemic embolism rose progressively with SBP, with a steepening gradient. At 140 vs. 120 mmHg, the RR was 1.51 for intracranial haemorrhage against 1.08 for ischaemic stroke, reaching 1.99 vs. 1.14 at 150 mmHg.

conclusionSBP exhibits a U-shaped relationship with all-cause mortality in patients with AF, balancing against a monotonic increase in ischaemic stroke and intracranial haemorrhage at higher pressures. A pragmatic target SBP of 120-130 mmHg with DBP kept above ∼75-80 mmHg, appears to optimize the balance between stroke prevention, bleeding risk, and survival.

Indexed as

Atrial FibrillationBlood PressureHypertensionIntracranial HemorrhagesIschemic StrokeFemaleHumansMaleNonlinear DynamicsRisk AssessmentRisk FactorsStrokeAtrial fibrillationDose-response meta-analysisHypertensionMortalityRisk factorStroke prevention

Identifiers

PMID42663497
PMCPMC13660803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.